SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nectar Lifesciences completes sale of API and formulations business

12 Nov 2025 Evaluate

Nectar Lifesciences has completed the slump sale of its active pharmaceutical ingredients (API) and formulations business (Business) to Ceph Lifesciences in accordance with the terms of the business transfer agreement (BTA). The company has also completed the asset sale to Ceph Lifesciences. The transfer is completed with effect from November 10, 2025. 

Incorporated in 1995, Nectar Lifesciences is a leading global manufacturer of cephalosporin antibiotics medicines.

Nectar Lifesciences Share Price

12.41 0.15 (1.22%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×